NSE - Delayed Quote INR

Glenmark Pharmaceuticals Limited (GLENMARK.NS)

1,541.70

-51.60

(-3.24%)

At close: January 10 at 3:29:56 PM GMT+5:30

Glenmark to market BeiGene’s oncology medicines in India

Glenmark will manage the necessary development, registration and distribution processes of Tislelizumab and Zanubrutinib.

Pharmaceutical Technology 7 months ago

GLENMARK.NS
-3.24%
BGNE
Cipla and Glenmark initiate recall of certain products in the US

Cipla USA is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution.

Pharmaceutical Technology 8 months ago

GLENMARK.NS
-3.24%
CIPLA.NS
-1.30%

Performance Overview

Return	GLENMARK.NS	S&P BSE SENSEX
YTD	-3.03%	-1.11%
1-Year	+74.15%	+8.39%
3-Year	+205.19%	+29.52%